학술논문
Results of a phase 2 trial of an oral CXCR4 antagonist, mavorixafor, for treatment of WHIM syndrome. Blood.(vol 136, pg 2994, 2020)
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15280020